Get the Stockscreener App
0.606
2.72%
0.0166
Agilon Health Inc stock is traded at $0.606, with a volume of 4.89M.
It is up +2.72% in the last 24 hours and down -26.89% over the past month.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
See More
Previous Close:
$0.5893
Open:
$0.5598
24h Volume:
4.89M
Relative Volume:
0.64
Market Cap:
$251.19M
Revenue:
$4.78B
Net Income/Loss:
$-284.68M
P/E Ratio:
-0.8782
EPS:
-0.69
Net Cash Flow:
$-184.84M
1W Performance:
+39.57%
1M Performance:
-26.89%
6M Performance:
-52.34%
1Y Performance:
-80.60%
1-Day Range:
$0.53
$0.6096
1-Week Range:
$0.3915
$0.617
52-Week Range:
$0.3375
$5.77
Agilon Health Inc Stock (AGL) Company Profile
Name
Agilon Health Inc
Sector
Industry
Phone
562-256-3800
Address
440 POLARIS PARKWAY, WESTERVILLE
Compare AGL vs HCA, THC, FMS, UHS, ENSG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AGL
Agilon Health Inc
|
0.6059 | 244.31M | 4.78B | -284.68M | -184.84M | -0.69 |
|
HCA
Hca Healthcare Inc
|
532.93 | 118.45B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
233.79 | 20.82B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.53 | 13.10B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
208.03 | 12.88B | 16.08B | 1.20B | 1.06B | 17.82 |
|
ENSG
Ensign Group Inc
|
215.00 | 12.45B | 4.11B | 239.98M | 193.10M | 4.12 |
Agilon Health Inc Stock (AGL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-20-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Aug-06-25 | Downgrade | Citigroup | Buy → Neutral |
| Apr-25-25 | Upgrade | Citigroup | Neutral → Buy |
| Apr-08-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jan-10-25 | Upgrade | Citigroup | Sell → Neutral |
| Jan-10-25 | Initiated | Needham | Hold |
| Dec-16-24 | Initiated | Macquarie | Neutral |
| Dec-11-24 | Initiated | Bernstein | Mkt Perform |
| Nov-11-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Nov-08-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-30-24 | Downgrade | Citigroup | Neutral → Sell |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Underperform |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| Apr-22-24 | Initiated | Citigroup | Neutral |
| Mar-06-24 | Initiated | Barclays | Underweight |
| Feb-26-24 | Downgrade | Jefferies | Buy → Hold |
| Feb-26-24 | Downgrade | TD Cowen | Outperform → Market Perform |
| Jan-08-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jan-08-24 | Downgrade | Stifel | Buy → Hold |
| Jan-08-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-05-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-05-24 | Downgrade | Truist | Buy → Hold |
| Dec-11-23 | Downgrade | Goldman | Buy → Neutral |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Nov-21-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-20-23 | Initiated | The Benchmark Company | Buy |
| Jun-13-23 | Initiated | Evercore ISI | In-line |
| Dec-09-22 | Initiated | Stifel | Buy |
| Sep-14-22 | Initiated | RBC Capital Mkts | Outperform |
| Sep-12-22 | Initiated | Goldman | Buy |
| Sep-07-22 | Resumed | Truist | Buy |
| Jun-24-22 | Initiated | BTIG Research | Neutral |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Oct-20-21 | Initiated | Jefferies | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| May-11-21 | Initiated | William Blair | Outperform |
| May-10-21 | Initiated | BofA Securities | Buy |
| May-10-21 | Initiated | Deutsche Bank | Buy |
| May-10-21 | Initiated | Goldman | Buy |
| May-10-21 | Initiated | JP Morgan | Overweight |
| May-10-21 | Initiated | Truist | Buy |
| May-10-21 | Initiated | Wells Fargo | Overweight |
| May-10-21 | Initiated | Wolfe Research | Outperform |
View All
Agilon Health Inc Stock (AGL) Latest News
Deadline Alert: agilon health, inc. (AGL) Shareholders Who - GlobeNewswire
Compared to Estimates, Agilon (AGL) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
AGILON HEALTH, INC. (NYSE: AGL) SHAREHOLDER ALERT Bernstein - GlobeNewswire
Agilon Health Q4 Earnings Call Highlights - Yahoo Finance
Agilon Health Q4 2025 Earnings Call Transcript - MarketBeat
Agilon Health (NYSE:AGL) Announces Quarterly Earnings Results, Misses Expectations By $0.19 EPS - MarketBeat
agilon health (AGL) Q4 2025 Earnings Transcript - AOL.com
agilon health Q4 2025 slides: path to breakeven after $296M loss - Investing.com
agilon health Q4 2025 slides: path to breakeven after $296M loss By Investing.com - Investing.com South Africa
Earnings call transcript: Agilon Health Q4 2025 misses EPS, sees revenue growth - Investing.com
Agilon Health Deadline: AGL Investors Have Opportunity to Lead a - GuruFocus
AGILON HEALTH ($AGL) Releases Q4 2025 Earnings - Quiver Quantitative
Agilon Health Q4 Earnings Beat Expectations Despite EPS Miss - Intellectia AI
Agilon: Q4 Earnings Snapshot - marketscreener.com
Agilon Health Reports 2025 Losses, Outlines 2026 Turnaround - TipRanks
Agilon Health Q4 revenue beats estimates - TradingView
Agilon Health Deadline: AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit First Filed by the Rosen Law Firm - Barchart.com
agilon health’s (NYSE:AGL) Q4 CY2025 Sales Top Estimates - TradingView
Agilon Health: Q4 Earnings Insights - Benzinga
Agilon Health tumbles 8% on wider than expected Q4 loss as total membership decreases - Investing.com
Agilon Health Inc. (AGL) Misses Q4 EPS by 19c - StreetInsider
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
After $296M loss, agilon health projects near-breakeven 2026 - Stock Titan
agilon health, inc. (AGL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
AGILON HEALTH, INC. (NYSE: AGL) DEADLINE ALERT Bernstein Liebhard LLP Reminds agilon health, inc. Investors of Upcoming Deadline - ACCESS Newswire
AGILON DEADLINE MARCH 2nd: Bragar Eagel & Squire, P.C. - GlobeNewswire
AGILON DEADLINE MARCH 2nd: Bragar Eagel & Squire, P.C. Urgently Reminds Agilon Health Investors with Larges Losses to Contact the Firm Before the Lead Plaintiff Deadline - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in agilon health, inc. of Class Action Lawsuit and Upcoming Deadlines - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of agilon health, inc. Investors - GlobeNewswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 2, 2026 in agilon health, inc. LawsuitAGL - PR Newswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
What To Expect From Agilon Health Inc (AGL) Q4 2025 Earnings - GuruFocus
agilon health Earnings: What To Look For From AGL - Finviz
Levi & Korsinsky Reminds agilon health, inc. Investors of - GlobeNewswire
agilon health, inc. (NYSE: AGL) Investor Alert: Deadline in Lawsuit on March 2, 2026 - openPR.com
iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know - Yahoo Finance
AGL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that agilon health, inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Agilon Health, Inc. (NYSE:AGL) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
ROSEN, A HIGHLY RANKED LAW FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
AGILON DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages agilon health, inc. Investors with ... - Caledonian Record
AGL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds agilon health (AGL) Investors of Securities Class Action Deadline on March 2, 2026 (2026-02-21) - Seeking Alpha
AGL Class Action Reminder: Stockholders Who Lost Money Investing in Agilon Health, Inc. Should Contact Robbins LLP for Information About Recovering Their Losses - ACCESS Newswire
AGL SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds ag - GuruFocus
Agilon Health Deadline: AGL Investors with Losses in Excess of $100K Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit First Filed by the Rosen Law Firm - The Malaysian Reserve
Agilon Health Deadline: AGL Investors with Losses in Excess of $ - GuruFocus
Agilon Health Deadline: AGL Investors with Losses in Excess of $100K Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit First Filed by the Rosen Law Firm – Company Announcement - Financial Times
AGL SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds agilon health (AGL) Investors of Securities Class Action Deadline on March 2, 2026 – Company AnnouncementFT.com - Financial Times
AGL DEADLINE NOTICE: agilon health, inc. Investors Encouraged to Contact Kirby McInerney LLP By March 2, 2026 - ACCESS Newswire
Notice of Securities Fraud Lawsuit Against Agilon Health, Inc. - Intellectia AI
Agilon Health Inc Stock (AGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.86%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):